Monitor future Form 4 filings by Patrick Kane for any open-market purchases or sales, which would provide insight into insider sentiment. No immediate trading signal from this initial filing.
INSM drugs
INSM drug pipeline →How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+5- T+0 · Nov 4 $110.00entry
- T+1 · 12d ago −1.13%α +3.28% · $108.76
- T+5 · 6d ago +9.77%α +10.69% · $120.75
- T+8 · todayOpen
- T+20 · in 16d Pending
- T+60 · in 3mo Pending
Price Chart
How similar events traded
Executive Summary
Patrick Kane filed a Form 3 initial statement of beneficial ownership upon becoming Corporate Controller of Insmed, disclosing 9,921 shares of common stock and multiple stock option grants with exercise prices ranging from $17.07 to $177.12. This is a routine insider onboarding filing with no material impact on the company's financials or operations.
Key Facts
- Patrick Kane appointed Corporate Controller of Insmed Inc.
- Form 3 filed on 2026-11-03 for period ending 2026-10-30.
- Disclosed 9,921 shares of common stock held directly.
- Disclosed 10 stock option grants with exercise prices from $17.07 to $177.12, totaling 26,543 option shares.
- Options vest over multi-year schedules under the company's 2019 Incentive Plan.
- Also disclosed restricted stock units (RSUs) with vesting over four years.
Financial Impact
No financial impact; routine insider ownership disclosure.
Risk Factors
- No material risks identified from this routine filing.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 3 Filing (Primary) | 0002162177-26-000003 |
| Document: 0002162177-26-000003-index-headers.html | 0002162177-26-000003 |
| Document: 0002162177-26-000003-index.html | 0002162177-26-000003 |
| Document: 0002162177-26-000003.txt | 0002162177-26-000003 |
Track record
24 reports on INSM
5 of 7 bullish or bearish reports moved the stock their way by T+20. Best: +31.86% at T+60 after the Mar 30, 2026 report. 8 of 9 went positive at some point.
Filters
- Nov 3, 202613d ago 144 Neutral 2/10 Entry $110.00 Now $122.88 +11.71% settles Dec 3
- Nov 3, 202613d ago 3 Neutral 1/10 Viewing Entry $110.00 Now $122.88 +11.71% settles Dec 3
- Oct 29, 202618d ago 8-K Bullish 6/10 Entry $111.59 Now $122.88 +10.12% settles Nov 27
- Oct 20, 202627d ago Institutional Cluster Bullish 4/10 Entry $94.04 Now $122.88 +30.67% settles Nov 18
- Oct 20, 202627d ago 8-K Neutral 3/10 Entry $95.67 Now $122.88 +28.44% settles Nov 17
- Oct 5, 20266w ago 8-K Neutral 4/10 Entry $103.83 to $112.58 Now $122.88 +18.35% ▲ +8.43% +10.89% vs SPY
- Aug 19, 202612w ago Insider Cluster Neutral 4/10 Entry $125.08 to $120.00 Now $122.88 −1.76% ▼ −4.06% −4.19% vs SPY
- Aug 12, 202613w ago Insider Cluster Neutral 4/10 Entry $126.33 to $129.41 Now $122.88 −2.73% ▲ +2.44% +4.19% vs SPY
- Aug 6, 202614w ago 8-K Bullish 8/10 Entry $132.55 to $126.68 Now $122.88 −7.30% ▼ −4.43% −5.03% vs SPY
- Jul 24, 202616w ago Institutional Cluster Neutral 4/10 Entry $106.92 to $125.77 Now $122.88 +14.93% ▲ +17.63% +14.00% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers